These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30416771)

  • 1. Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation.
    Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
    J Thorac Dis; 2018 Sep; 10(9):5246-5253. PubMed ID: 30416771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
    Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis.
    Kim SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    J Korean Med Sci; 2015 Jun; 30(6):737-42. PubMed ID: 26028926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.
    Ma Y; Niu Y; Tian G; Wei J; Gao Z
    Chron Respir Dis; 2015 Aug; 12(3):222-9. PubMed ID: 25882894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk assessment of intensive care unit admission for postoperative patients with stable chronic obstructive pulmonary disease].
    Fan J; Zhao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1209-1214. PubMed ID: 34955130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
    Ghobadi H; Hosseini N; Aslani MR
    Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.
    Jin J; Yu W; Li S; Lu L; Liu X; Sun Y
    Medicine (Baltimore); 2016 Jul; 95(29):e4219. PubMed ID: 27442646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk.
    Kwok WC; Teo KC; Lau KK; Ho JC
    BMC Pulm Med; 2024 Feb; 24(1):80. PubMed ID: 38350918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis.
    Nigro E; Mosella M; Daniele A; Mallardo M; Accardo M; Bianco A; Perrotta F; Scialò F
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study.
    Liu W; Xu Y; Yang L; Zhan S; Pang K; Lin H; Qin H; Zhang P
    Sci Rep; 2024 May; 14(1):10108. PubMed ID: 38698005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bronchiectasis on the exacerbation and mortality of chronic obstructive pulmonary disease.
    Fendoğlu TZ; Köktürk N; Yapar D; Kılıç P; Kılıç K; Erbaş G
    Clin Respir J; 2021 Oct; 15(10):1113-1120. PubMed ID: 34224649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin, erythrocyte sedimentation rate and C-reactive protein in acute pulmonary exacerbations of cystic fibrosis.
    Loh G; Ryaboy I; Skabelund A; French A
    Clin Respir J; 2018 Apr; 12(4):1545-1549. PubMed ID: 28884501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Zhang J; Bai C
    Tanaffos; 2018 Jan; 17(1):13-21. PubMed ID: 30116274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
    Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
    Wang JX; Li HQ; Zhang F; Ning W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011699. PubMed ID: 28952156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.